Myelodysplastic Syndromes (MDS)

Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care

Read more about Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care

Hematopoietic stem cell transplantation (HCT) is indicated for patients with higher-risk (HR) myelodysplastic syndromes myelodysplastic syndromes

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Read more about Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Health-related quality of life (HRQoL) and vulnerability are variably affected in patients with myelodysplastic syndromes myelodysplastic syndrom

Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes

Read more about Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes

Objectives: This study aimed to describe the burden of thrombocytopenia thrombocytopenia: (throm-buh-sie-tuh-PEE-nee-uh) A condition in which there i

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Read more about Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?

Read more about Are we ready to ring in a new upfront therapy in lower-risk myelodysplastic syndromes?

Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review

Read more about Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review

Anemia Anemia: (uh-NEE-mee-uh) A condition in which there is a shortage of red blood cells in the bloodstream. This causes a low red blood cell count.

Considerations for Drug Development in Myelodysplastic Syndromes

Read more about Considerations for Drug Development in Myelodysplastic Syndromes

Myelodysplastic syndromes Myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders where the bone

Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review

Read more about Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review

Dysregulation of the innate immune system and inflammatory-related pathways has been implicated in hematopoietic defects in the bone marrow bone marrow: The soft, spongy tissue inside most bones.

Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress

Read more about Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress

Introduction: Patients with myeloid neoplasms such as myelodysplastic syndromes myelodysplastic syndromes:

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Read more about Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Background: Erythropoiesis-stimulating agents (ESAs) are the standard-of-care treatment for anaemia in most patients with lower-risk myelodysplastic syndromes

Subscribe to Myelodysplastic Syndromes (MDS)